Injectable Antineoplastic Agent for Multiple Myeloma
Created 3 months ago by marykudro

Carfilzomib in combination with other drugs is prescribed to treat relapsed multiple myeloma (multiple myeloma that has returned) and for refractory multiple myeloma (MM that no longer responds to treatment). The carfilzomib 60 mg injection is a commonly existing strength and should be administered as an infusion into a vein. It is given by a healthcare professional in a medical office or clinic usually over a period of 10 or 30 minutes. Carfilzomib falls under the class of medications known as proteasome inhibitors. It works in order to inhibit or resist the growth of cancer cells in a patient's body.